With the rising adoption of checkpoint inhibitors and combination therapies, BAVENCIO's market growth is driven by expanding indications and strategic partnerships. However, competition from ...

DelveInsight's "BAVENCIO Market Size, Forecast, and Market Insight Report" highlights the details around BAVENCIO, a human ...

A research team led by Prof. Zeng Zhutian from the University of Science and Technology of China (USTC) has identified and ...

While randomized comparative trials are needed, a relatively new treatment option for upper urinary tract cancers shows ...

A phase 3 trial for myelofibrosis found that adding pelebresib to ruxolitinib was more effective than ruxolitinib alone and did not significantly increase side effects.

Mitomycin C gel instillation is a nonsurgical, kidney-sparing primary treatment option for patients with low-grade upper tract urothelial carcinoma (UTUC).

Discover a study where results suggest trends towards overall survival and progression-free survival improvements with ...

BALVERSA (erdafitinib) has strong market potential in the FGFR-altered urothelial carcinoma space, particularly as a targeted therapy for patients with FGFR2/3 mutations. With the growing emphasis on ...

New Zealanders now have funded access to a global standard of care treatment for a form of liver cancer, Hepatocellular Carcinoma (HCC), which, unlike many other cancers has a rapidly increasing rate ...

Exposure duration should be considered in safety assessments of first-line treatments in patients with locally advanced and metastatic urothelial cancers. Real-world evidence highlighted the ...

The standard treatment for patients with MIBC is radical ... However, over 50% of patients with urothelial cancer are 'unfit' (a GFR less than 60 mL/min and/or a performance status of two or ...

Some breast cancer cells are sensitive to estrogen. They need it to grow and spread. In order to fuel that growth, estrogen must attach itself to those breast cancer cells. Doctors think that ...